Dacryocystoplasty: treatment of epiphora by means of balloon dilation of the obstructed nasolacrimal duct system.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7972762.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To evaluate treatment of epiphora due to acquired stenotic obstruction of the nasolacrimal duct system with dacryocystoplasty (DCP), in which balloon dilation is used to alleviate the obstruction. Twenty patients (21 eyes) with epiphora due to obstructing lesions at the saccular or subsaccular level were treated with DCP. The authors used a catheter with a balloon diameter of only 3 mm to prevent damage to the nasolacrimal duct system and a nontraumatizing guide wire. Stent placement was not considered necessary. Follow-up ranged from 14 to 70 weeks. Cannulation was not possible in one case of complete obstruction. DCP was successfully performed in the other 20 cases. In 18 of these cases (90%), results comparable with those of dacryocystorhinostomy were achieved. No side effects were observed. DCP is potentially the treatment of choice for epiphora due to acquired stenotic obstruction of the nasolacrimal duct system.
Medical subject headings
- Catheterization
- Lacrimal Duct Obstruction
- Nasolacrimal Duct